ARIA
Ariad Pharmaceuticals Inc
ARIA
ARIA
Delisted
ARIA was delisted on the 15th of February, 2017.
200 hedge funds and large institutions have $2.13B invested in Ariad Pharmaceuticals Inc in 2016 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 66 increasing their positions, 73 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% less capital invested
Capital invested by funds: $2.28B → $2.13B (-$155M)
44% less call options, than puts
Call options by funds: $20.8M | Put options by funds: $37.3M
Holders
200
Holding in Top 10
9
Calls
$20.8M
Puts
$37.3M
Top Buyers
| 1 | +$36.4M | |
| 2 | +$21.1M | |
| 3 | +$20.7M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$18.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.2M |
Top Sellers
| 1 | -$64M | |
| 2 | -$24.5M | |
| 3 | -$13.9M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$13M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$12.4M |